Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Atorvastatin safety in Kawasaki disease patients with coronary artery aneurysms.

Niedra E, Chahal N, Manlhiot C, Yeung RS, McCrindle BW.

Pediatr Cardiol. 2014 Jan;35(1):89-92. doi: 10.1007/s00246-013-0746-9. Epub 2013 Jul 18.

PMID:
23864222
2.

Intensive lipid lowering with atorvastatin in patients with stable coronary disease.

LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, Gotto AM, Greten H, Kastelein JJ, Shepherd J, Wenger NK; Treating to New Targets (TNT) Investigators..

N Engl J Med. 2005 Apr 7;352(14):1425-35. Epub 2005 Mar 8.

3.
4.

Reaching recommended lipid and blood pressure targets with amlodipine/atorvastatin combination in patients with coronary heart disease.

Dorval JF, Anderson T, Buithieu J, Chan S, Hutchison S, Huynh T, Jobin J, Lonn E, Poirier P, Title L, Walling A, Tran T, Boudreau G, Charbonneau F, Genest J.

Am J Cardiol. 2005 Jan 15;95(2):249-53.

PMID:
15642561
5.
6.

Comment on atorvastatin safety in kawasaki disease patients with coronary artery aneurysms.

Tremoulet AH.

Pediatr Cardiol. 2014 Jan;35(1):93. doi: 10.1007/s00246-013-0805-2. Epub 2013 Sep 27. No abstract available.

PMID:
24072043
7.

Effect of pravastatin on endothelial dysfunction in children with medium to giant coronary aneurysms due to Kawasaki disease.

Duan C, Du ZD, Wang Y, Jia LQ.

World J Pediatr. 2014 Aug;10(3):232-7. doi: 10.1007/s12519-014-0498-5. Epub 2014 Aug 15.

PMID:
25124974
8.
9.

Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets?

Piorkowski M, Fischer S, Stellbaum C, Jaster M, Martus P, Morguet AJ, Schultheiss HP, Rauch U.

J Am Coll Cardiol. 2007 Mar 13;49(10):1035-42. Epub 2007 Feb 23.

10.

Author reply to comment on "atorvastatin safety in Kawasaki disease patients with coronary artery aneurysms".

Manlhiot C, McCrindle BW.

Pediatr Cardiol. 2014 Jan;35(1):94-5. doi: 10.1007/s00246-013-0806-1. Epub 2013 Oct 15. No abstract available.

PMID:
24126955
11.
12.
14.

Intensive versus moderate lipid lowering with statins after acute coronary syndromes.

Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM; Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators..

N Engl J Med. 2004 Apr 8;350(15):1495-504. Epub 2004 Mar 8. Erratum in: N Engl J Med. 2006 Feb 16;354(7):778.

15.

Interaction between a commercially available St. John's wort product (Movina) and atorvastatin in patients with hypercholesterolemia.

Andrén L, Andreasson A, Eggertsen R.

Eur J Clin Pharmacol. 2007 Oct;63(10):913-6. Epub 2007 Aug 15.

PMID:
17701167
16.

Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.

Davidson MH, Rooney MW, Drucker J, Eugene Griffin H, Oosman S, Beckert M; LCP-AtorFen Investigators..

Clin Ther. 2009 Dec;31(12):2824-38. doi: 10.1016/j.clinthera.2009.12.007.

PMID:
20110022
17.

Safety and efficacy of atorvastatin in heart transplant recipients.

Patel DN, Pagani FD, Koelling TM, Dyke DB, Baliga RR, Cody RJ, Lake KD, Aaronson KD.

J Heart Lung Transplant. 2002 Feb;21(2):204-10.

PMID:
11834348
18.

The effects of different doses of atorvastatin on plasma endothelin-1 levels in type 2 diabetic patients with dyslipidemia.

Lam HC, Chu CH, Wei MC, Keng HM, Lu CC, Sun CC, Lee JK, Chuang MJ, Wang MC, Tai MH.

Exp Biol Med (Maywood). 2006 Jun;231(6):1010-5.

PMID:
16741040
19.

Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets.

McCormack T, Harvey P, Gaunt R, Allgar V, Chipperfield R, Robinson P; IN-PRACTICE study..

Int J Clin Pract. 2010 Jul;64(8):1052-61. doi: 10.1111/j.1742-1241.2010.02429.x. Epub 2010 May 12.

PMID:
20487050
20.

Efficacy and safety of atorvastatin after pediatric heart transplantation.

Chin C, Gamberg P, Miller J, Luikart H, Bernstein D.

J Heart Lung Transplant. 2002 Nov;21(11):1213-7.

PMID:
12431495

Supplemental Content

Support Center